For comments, suggestions
Created with Raphaël 2.1.0 07.05.2014 Opening of the national phase 30.05.2014 Preliminary and substantive examination 29.08.2014 Establishment of the national regular filing 30.09.2014 Publication of the PCT application (A2) 31.07.2018 Publication of the decision of grant (B1) 31.01.2019 Completion of the opposition filing period 28.02.2019 Issuance of patent (C1) 17.05.2024 09.10.2024 Valid until 09.10.2025 Payment of maintenance fee 09.10.2032 Patent expiration date

Patent in force


(11)Number of the document4582
(21)Number of the applicationa 2014 0047
(22)Filing date of the application2012.10.09
 Date of filing the request for examination (de fond) 25.10.2016
(71)Name(s) of applicant(s), code of the countryORION CORPORATION, FI;
(72)Name(s) of inventor(s), code of the countryLINNANEN Tero, FI; WOHLFAHRT Gerd, FI; NANDURI Srinivas, IN; UJJINAMATADA Ravi, IN; RAJAGOPALAN Srinivasan, IN; MUKHERJEE Subhendu, IN;
(73)Name(s) of owner(s), code of the countryORION CORPORATION, FI;
(54)Title of the invention1-Phenyl-1H-benzimidazole derivatives as protein kinase inhibitors
(13)Kind-of-document code
C1, BOPI 02/2019
B1, BOPI 07/2018
A2, BOPI 09/2014
(51)International Patent Classification C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01); C07D 471/04 (2006.01); A61K 31/4184 (2006.01); A61K 31/4188 (2006.01); A61P 35/00 (2006.01);
(19)CountryFI
(41)Date of publication of the application2014.09.30
(45)Date of publication of patent granting decision:2018.07.31
(47)Date of issuance of patent2019.02.28
(30)Priority1306/KOL/2011, 2011.10.10, IN
(74)Patent attorneyANDRIEŞ Ludmila, Str. M.Costin 15/2, of. 19-20, MD-2045, Chişinău, Republica Moldova
 Substantive examiner(s)LEVIŢCHI Svetlana, STAFI Radu
(85)Date of introducing the national procedure2014.05.07
(86)International applicationPCT/FI2012/000040, 2012.10.09
(87)International publicationWO 2013/053983 A1, 2013.04.18
 Payment for maintenance up to the date2024.10.09
Up
/inventions/Details.aspx?id=a%202014%200047